Check out the companies making headlines in premarket trading. Robinhood — Shares of the brokerage firm jumped more than 6% after unveiling
Tag: Merck & Co Inc
Sickle cell disease gene therapies Casgevy Lyfgenia insurance cost issues
The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease,
JPMorgan says buy this immunology stock primed to rally nearly 40%
Immunovant could emerge as a key player in the autoimmune space, according to JPMorgan. The bank initiated coverage of the biotech stock
Q4 earnings shaping up to be the best of 2023
Traders work on the floor at the New York Stock Exchange on Feb. 1, 2024. Brendan McDermid | Reuters Here’s how big
Tesla is one of the most oversold stocks in the S&P 500
After plunging 26% this year, shares of electric vehicle maker Tesla could bounce back, at least according to one popular metric. Stocks
Stock futures fall ahead of big tech earnings and Fed meeting decision: Live updates
Traders work on the floor of the New York Stock Exchange during afternoon trading on January 22, 2024 in New York City.
Big pharma Merck, Bristol Myers, J&J prepare to lose revenue
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers
Fed meeting, labor report, Big Tech earnings
CNBC’s Jim Cramer on Friday looked to next week’s happenings on Wall Street, laying out how to prepare for a slew of
Merck, J&J CEOs agree to testify in Senate hearing on drug prices
US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare
Jim Cramer’s 4 stock ideas from JPMorgan Healthcare Conference
Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech
No More Posts Available.
No more pages to load.